Target intelligence / Profile preview

Matrix protein 1 (M1) of influenza A virus (M1)

Target
M1
Molecular classification
Viral structural protein, Matrix protein
01

Overview

Matrix protein 1 (M1) is a multifunctional structural protein of the influenza A virus that forms a shell beneath the viral lipid envelope, providing structural integrity to the virion. It plays a pivotal role in the viral life cycle, including the nuclear export of viral ribonucleoproteins (vRNPs) and the coordination of viral assembly and budding at the host cell membrane (UniProt P03485). Because M1 is one of the most highly conserved proteins across different influenza A subtypes, its epitopes are major targets for the development of universal influenza vaccines and broadly cross-reactive therapeutic antibodies (PubMed: 31503040). While M1 is internally located in the mature virion, it is transiently exposed during the uncoating process and expressed on the surface of infected cells, making it a viable target for T-cell mediated clearance and antibody-dependent cellular cytotoxicity (ADCC) (PubMed: 25100859). Targeting conserved M1 epitopes aims to provide broad protection against diverse seasonal and pandemic influenza strains that frequently escape immunity directed at the more variable surface glycoproteins like hemagglutinin.

Other names
M1 proteinInfluenza A virus matrix protein 1Matrix protein M1IAV M1
02

Mechanism of action

Inhibition of viral assembly and budding, stabilization of viral ribonucleoprotein complexes to prevent nuclear export, and induction of cross-reactive T-cell or antibody-mediated immunity against conserved viral epitopes.

03

Biological functions

Viral assemblyViral buddingNuclear export of viral ribonucleoproteinsStructural integrity of the virionRegulation of viral RNA transcription
04

Disease associations

InfectionInfluenza A
05

Safety considerations

Potential for immunopathologyLow accessibility of internal epitopes to circulating antibodiesRequirement for robust cellular immune responses for efficacy
06

Interacting drugs

M1-specific monoclonal antibodies (experimental)

1 more in the full profile.

07

Biomarkers

M1-specific antibody titersM1-specific CD8+ T-cell responseViral load (M1 RNA/protein levels)

Beyond the preview

Go deeper on Matrix protein 1 (M1) of influenza A virus (M1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix protein 1 (M1) of influenza A virus (M1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call